newdrugapprovals.org
BICTEGRAVIR, NEW PATENT, WO 2018005328, CONCERT PHARMA
BICTEGRAVIR, NEW PATENT, WO 2018005328, CONCERT PHARMA WO2018005328) DEUTERATED BICTEGRAVIR CONCERT PHARMACEUTICALS, INC. TUNG, Roger, D.; (US) Concert CEO Roger Tung Novel deuterated forms of bic…